Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$7.29 - $10.14 $11,970 - $16,649
1,642 Added 125.54%
2,950 $21,000
Q3 2022

Nov 14, 2022

BUY
$10.02 - $26.15 $13,106 - $34,204
1,308 New
1,308 $13,000
Q2 2020

Aug 11, 2020

SELL
$4.55 - $6.19 $7,229 - $9,835
-1,589 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$3.99 - $5.46 $24,498 - $33,524
-6,140 Reduced 79.44%
1,589 $7,000
Q4 2019

Feb 13, 2020

SELL
$4.34 - $5.86 $20,979 - $28,327
-4,834 Reduced 38.48%
7,729 $38,000
Q1 2019

Apr 16, 2019

SELL
$5.66 - $7.89 $50,085 - $69,818
-8,849 Reduced 41.33%
12,563 $76,000
Q4 2018

Jan 17, 2019

BUY
$4.77 - $7.9 $102,097 - $169,091
21,404 Added 267550.0%
21,412 $169,000
Q3 2018

Nov 02, 2018

BUY
$6.03 - $8.34 $48 - $66
8 New
8 $0

Others Institutions Holding SIGA

About SIGA TECHNOLOGIES INC


  • Ticker SIGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 73,024,096
  • Market Cap $405M
  • Description
  • SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...
More about SIGA
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.